文献速递糖尿病

1型糖尿病微血管并发症的发生及并发危险因素的影响:来自观察性临床队列的多状态模型

Development of Microvascular Complications and Effect of Concurrent Risk Factors in Type 1 Diabetes: A Multistate Model From an Observational Clinical Cohort Study.
PubMed 文献 · Diabetes Care · 2018-08-21

该研究基于Steno糖尿病中心哥本哈根临床队列3586例1型糖尿病患者,采用多状态模型分析糖尿病肾病、视网膜病变和神经病变的发生,发现已有两种并发症者后续发生糖尿病肾病的发生率比为3.2(95%CI 2.3-4.5),且部分危险因素的效应受并发症负担修饰。

要点

  • 已有两种并发症者后续糖尿病肾病发生率比为3.2(95%CI 2.3-4.5)。
  • HbA1c、糖尿病病程、收缩压、BMI、eGFR、LDL胆固醇的效应未被并发并发症负担修饰。
  • 性别和心血管疾病的效应被并发并发症负担修饰。

核心结论

  • 1型糖尿病微血管并发症风险高度取决于并发并发症负担和危险因素谱。
  • 结果强调无论已有并发症数量多少,都应关注危险因素以预防进一步微血管并发症。

研究设计与样本

  • 观察性临床队列研究,使用Steno糖尿病中心哥本哈根临床队列,纳入3586例个体,从电子病历提取信息,采用多状态模型估计并发症发生率。

主要发现

  • 与无并发症个体相比,已有两种并发症者糖尿病肾病发生率比为3.2(95%CI 2.3-4.5),视网膜病变为2.1(95%CI 1.5-3.1),神经病变为1.7(95%CI 1.2-2.4)。
  • 模型纳入糖尿病病程、日历时间和年龄作为时间尺度,以及性别、HbA1c、降脂和降压治疗、收缩压、BMI、eGFR、心血管疾病、LDL胆固醇、胰岛素剂量(单位/kg/天)和吸烟状态作为协变量。
  • HbA1c、糖尿病病程、收缩压、BMI、eGFR和LDL胆固醇的效应未被并发并发症负担修饰,而性别和心血管疾病的效应被修饰。

临床怎么用

  • 在1型糖尿病管理中,无论患者已有多少种并发症,均应关注HbA1c、血压、BMI、eGFR、LDL胆固醇等危险因素以预防进一步微血管并发症。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Type 1 diabetes is a complex disease, and development of multiple complications over time can be analyzed only with advanced statistical methods. This study describes the development of microvascular complications and explores the effect of complication burden and important concurrent risk factors by applying a multistate model. RESEARCH DESIGN AND METHODS: We used a clinical cohort at the Steno Diabetes Center Copenhagen to study the development of diabetic kidney disease, retinopathy, and neuropathy. We extracted information from electronic patient records and estimated incidence rates of complications by concurrent complication burden. We explored the extent to which concurrent complications modify the effect of selected risk factors on the development of microvascular complications. RESULTS: We included 3,586 individuals. Incidence rate ratios in individuals with two previous complications were 3.2 (95% CI 2.3-4.5) for diabetic kidney disease, 2.1 (1.5-3.1) for retinopathy, and 1.7 (1.2-2.4) for neuropathy compared with individuals without complications. The models included diabetes duration; calendar time and age as timescales; and sex, HbA1c, lipid-lowering and antihypertensive treatment, systolic blood pressure, BMI, estimated glomerular filtration rate (eGFR), cardiovascular disease (CVD), LDL cholesterol, insulin dose (units/kg/day), and smoking status as covariates. Effects of HbA1c, diabetes duration, systolic blood pressure, BMI, eGFR, and LDL cholesterol where not modified by concurrent complication burden, whereas the effect of sex and CVD were. CONCLUSIONS: The risk of microvascular complications highly depends on the concurrent complication burden and risk factor profile in individuals with type 1 diabetes. The results emphasize attention to risk factors, regardless of existing number of complications, to prevent development of further microvascular complications.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Bjerg L, Hulman A, Carstensen B, et al. Development of Microvascular Complications and Effect of Concurrent Risk Factors in Type 1 Diabetes: A Multistate Model From an Observational Clinical Cohort Study. Diabetes Care. 2018. PMID: 30131399. doi:10.2337/dc18-0679

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。